| Application no. and date | 14708507.0 (espacenet) (Federated) (European Patent Register), 20140224 | | Patent/reg. no. and date | DK/EP 2961771, 20200101 | | Publication date | 20160106 | | Priority no. and date | EP 13156686, 20130226 | | EP pub. no. and date |
EP 2961771 20160106 | | Effective date | | | Applicant/owner | Roche Glycart AG, Wagistrasse 10
8952 Schlieren, CH | | Applicant ref. no. | P71284DK01 | | Inventor | Umana, Pablo, Felsenrainstrasse 28
8832 Wollerau, CH,
MOESSNER, Ekkehard, Felsenburgweg 5
8280 Kreuzlingen, CH,
HOFER, Thomas, Alte Muehlackerstrasse 50
8046 Zuerich, CH,
KLEIN, Christian, Chapfstrasse 26B
8906 Bonstetten, CH,
NEUMANN, Christiane, Im Gupfen 16
8166 Niederweningen, CH,
HOSSE, Ralf, Hombergweg 17
8932 Mettmenstetten, CH,
WEINZIERL, Tina, Rugghoelzli 11
5453 Remetschwil, CH,
BACAC, Marina, Kuerbergsteig 6
8049 Zuerich, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) | | Title | Bispecifikke, T-celle-aktiverende, antigenbindende molekyler, der er specifikke for CD3 og CEA | | Int. application no. | EP2014053490 | | Int. publication no. | WO2014131712 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
